Trends in outcomes, cost, and readmissions of transcatheter edge to edge repair in the United States (2014-2018)

Catheter Cardiovasc Interv. 2022 Feb;99(3):949-955. doi: 10.1002/ccd.29957. Epub 2021 Sep 14.

Abstract

Introduction: Despite the growth in transcatheter edge-to-edge repair (TEER) volume in the United States, data on the temporal changes in procedural outcomes are lacking.

Methods: We utilized the National Readmission Database to assess the annual changes in patient's characteristics, in-hospital outcomes, cost, and readmissions for patients who underwent TEER between January 1, 2014 and December 31, 2018. Outcomes of interest included mortality, major adverse cardiovascular events (MACE) and any adverse event (AE). We also assessed length of stay and cost.

Results: A total of 22,692 hospitalizations were included. The mean age increased from 75.2 ± 12.9 in 2014 to 78.1 ± 9.8 years in 2018. Changes in the prevalence of risk factors were heterogenous. The incidence of in-hospital mortality decreased from 4.0% in 2014 to 2.0% in 2018. Both MACE and any AE decreased significantly. Although the incidence of 30-day readmission remained stable, there was a trend towards a temporal increase in both 90-day and 180-day. The adjusted median length of stay of the index admission decreased by 50% and this trend was associated with a $2100 reduction in risk and inflation adjusted in-hospital cost, however, this reduction was offset by the increased total cost of readmissions within the first 6 months resulting in similar net-cost.

Conclusion: The volume of TEER has grown substantially between 2014 and 2018 coupled with a temporal improvement in in-hospital outcomes and reduction in cost and length of stay. Re-hospitalization rates after TEER remained steady at 30-day and trended towards worsening overtime at 90- and 180-days.

Keywords: health care outcomes; mitral valve disease; percutaneous intervention.

MeSH terms

  • Hospital Costs*
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Patient Readmission*
  • Risk Factors
  • Treatment Outcome
  • United States / epidemiology